2011

  1. Home
  2. 2011

Interleukin-27: a master regulator in inflammation.

Fearon U.

Arthritis Rheum. 2011 Aug;63(8):2157-60

Hypoxia induces mitochondrial mutagenesis and dysfunction in inflammatory arthritis.

Biniecka M, Fox E, Gao W, Ng CT, Veale DJ, Fearon U, O’Sullivan J.

Arthritis Rheum. 2011 Aug;63(8):2172-82.

Successful tumour necrosis factor (TNF) blocking therapy suppresses oxidative stress and hypoxia-induced mitochondrial mutagenesis in inflammatory arthritis.

Biniecka M, Kennedy A, Ng CT, Chang TC, Balogh E, Fox E, Veale DJ, Fearon U, O’Sullivan JN.

Arthritis Res Ther. 2011 Jul 25;13(4):R121.

Differential expression of NK receptors CD94 and NKG2A by T cells in rheumatoid arthritis patients in remission compared to active disease.

Walsh CE, Ryan EJ, O’Farrelly C, Golden-Mason L, FitzGerald O, Veale DJ, Bresnihan B, Fearon U. PLoS One. 2011;6(11):e27182.

IL-17A expression is localised to both mononuclear and polymorphonuclear synovial cell infiltrates.

Moran EM, Heydrich R, Ng CT, Saber TP, McCormick J, Sieper J, Appel H, Fearon U, Veale DJ. PLoS One. 2011;6(8):e24048

Toll-like receptor 2 induced angiogenesis and invasion is mediated through the Tie2 signalling pathway in rheumatoid arthritis.

Saber T, Veale DJ, Balogh E, McCormick J, NicAnUltaigh S, Connolly M, Fearon U. PLoS One. 2011;6(8):e23540.